Cell line · CVCL_0022
U-87MG ATCC
Cancer cell line, Homo sapiens. Glioblastoma. Cellosaurus records it as misidentified. 288 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Cite this record
ConductScience Library. U-87MG ATCC. Cell lines, record CVCL_0022. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_0022
On this page
Cell line
As Cellosaurus gives it.
- Name
- U-87MG ATCC
- Accession
- CVCL_0022
- RRID
- RRID:CVCL_0022
- Synonyms
- U-87MG, U-87 MG, U87 MG, U-87-MG, U87-MG, U87MG, U-87, U87, 87 MG, 87MG
- Species
- Homo sapiens (Human)
- Sex
- Male
- Age at sampling
- Age unspecified
- Category
- Cancer cell line
- Diseases
- Glioblastoma (NCIt C3058); Glioblastoma (ORDO Orphanet_360)
- Entry created
- 2012-04-04
- Entry updated
- 2026-06-25
Source Cellosaurus
Problems1
| Problem | Cellosaurus's note |
|---|---|
| Misidentified | This cell line is not the original glioblastoma cell line established in 1968 at the University of Uppsala. As described in PubMed=27582061 it is most probably also a glioblastoma cell line but whose origin is unknow. See U-87MG Uppsala (Cellosaurus=CVCL_GP63) for the original U-87MG cell line. |
Source Cellosaurus
Papers288
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| A guide to selecting high-performing antibodies for ASM (UniProt ID: P17405) for use in western blot and immunoprecipitation. | F1000Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Dactolisib outperforms Rapamycin in potentiating apoptosis induced by XPO1, Bcl-2 and Mcl-1 blockade in preclinical glioblastoma models. | FEBS Open Bio | 2026 | Its Methods give the RRID and name the line | PubMed | |
| HBQ1 Acts as a Prognostic Biomarker and Tumor Suppressor Linked to Antigen Presentation in Glioma. | Cell Biochem Funct | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Low-Density Lipoprotein Receptor-Targeted Biomimetic Nanoplatform Suppresses Glioblastoma Stemness and Remodels Antitumor Immunity via Dual Metabolic Disruption. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| 3D Bioprinted Blood-Brain-Tumor Barrier Spheroid-Based In Situ Evaluation of Anticancer Compounds Against Glioblastoma: ROS-Producing Ruthenium as a Potential Therapeutic Candidate. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Trimodal ultrasound imaging of brain-tumor interaction. | iScience | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Targeting LDHA Palmitoylation Sensitizes GBM to Chemoradiotherapy via Suppressing Palmitic Acid Induced Glycolytic Reprogramming. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| PLOD1 Catalytic Activity Stabilizes ENO1 by Limiting FBXW7-dependent Degradation to Promote Glycolysis and TMZ Resistance in Glioblastoma. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| In Vitro Effects of an Olive Polyphenol-Bromelain Formulation on U87MG Glioblastoma Cells: Viability, Cell-Cycle Distribution, Cytokine Release, and Total Antioxidant Capacity. | Molecules | 2026 | Its Methods give the RRID and name the line | PubMed | |
| A guide to selecting high-performing antibodies for Netrin-1 (UniProt ID: O95631) for use in western blot and immunoprecipitation. | F1000Res | 2026 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 288
See all 288 papersRelatives200
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Derived from it | Abcam U-87MG ABCA1 KO | CVCL_D1RF | Has a recorded problem | Cell lines |
| Derived from it | Abcam U-87MG ABL1 KO | CVCL_D1RG | Has a recorded problem | Cell lines |
| Derived from it | Abcam U-87MG ADAM10 KO | CVCL_D1RH | Has a recorded problem | Cell lines |
| Derived from it | Abcam U-87MG ADRB3 KO | CVCL_D1RI | Has a recorded problem | Cell lines |
| Derived from it | Abcam U-87MG AKR1C1 KO | CVCL_D1RJ | Has a recorded problem | Cell lines |
| Derived from it | Abcam U-87MG ALDH1A1 KO | CVCL_D1RK | Has a recorded problem | Cell lines |
| Derived from it | Abcam U-87MG APP KO | CVCL_D1RL | Has a recorded problem | Cell lines |
| Derived from it | Abcam U-87MG ASNS KO | CVCL_D1RM | Has a recorded problem | Cell lines |
| Derived from it | Abcam U-87MG ASS1 KO | CVCL_D1RN | Has a recorded problem | Cell lines |
| Derived from it | Abcam U-87MG ATP1A3 KO | CVCL_D1RP | Has a recorded problem | Cell lines |
1 to 10 of 200
See all 200 relativesCell banks19
| Cell bank | Catalog number | Status | Source |
|---|---|---|---|
| ATCC | HTB-14 | ATCC | |
| Abcam | ab278079 | Abcam | |
| AddexBio | C0005002/71 | Cellosaurus | |
| BCRC | 60360 | BCRC | |
| BCRJ | 0241 | BCRJ | |
| BEI_Resources | ARP-2188 | BEI_Resources | |
| CCTCC | GDC0157 | Cellosaurus | |
| CLS | 300367 | CLS | |
| ECACC | 89081402 | ECACC | |
| EDITGENE | EDC00287 | EDITGENE |
1 to 10 of 19
See all 19 cell banksData dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_0022
GET https://conductscience.org/api/cell-lines/v1/CVCL_0022/papers?page=2